Form 4 for QNCX Quince Therapeutics, Inc.
Accepted 2022-09-08 00:00:00 ET · period of report 2022-09-06 · accession 0001209191-22-049221 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-09-08 | 2022-09-06 | QNCX | Monohon Ted | CAO, VP | F - Tax | $1.64 | -1,520 | 31.0K | -5% | -$2,493 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-09-06 | F | D | 1,520 | $1.64 | 30,951 | D | — | — | (F1) Represents shares sold to satisfy tax withholding obligations that arose in connection with the vesting of 4,250 shares of Restricted Stock Units granted on March 3, 2022. The sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 23, 2022. |